The DOI matches its Crossref record; 50 of the 50 references it cites were found in a registry or an index.
An Alternatively Spliced Variant of CXCR3 Mediates the Inhibition of Endothelial Cell Growth Induced by IP-10, Mig, and I-TAC, and Acts as Functional Receptor for Platelet Factor 4
Open accessAbstract
The chemokines CXCL9/Mig, CXCL10/IP-10, and CXCL11/I-TAC regulate lymphocyte chemotaxis, mediate vascular pericyte proliferation, and act as angiostatic agents, thus inhibiting tumor growth. These multiple activities are apparently mediated by a unique G protein–coupled receptor, termed CXCR3. The chemokine CXCL4/PF4 shares several activities with CXCL9, CXCL10, and CXCL11, including a powerful angiostatic effect, but its specific receptor is still unknown. Here, we describe a distinct, previously unrecognized receptor named CXCR3-B, derived from an alternative splicing of the CXCR3 gene that mediates the angiostatic activity of CXCR3 ligands and also acts as functional receptor for CXCL4. Human microvascular endothelial cell line-1 (HMEC-1), transfected with either the known CXCR3 (renamed CXCR3-A) or CXCR3-B, bound CXCL9, CXCL10, and CXCL11, whereas CXCL4 showed high affinity only for CXCR3-B. Overexpression of CXCR3-A induced an increase of survival, whereas overexpression of CXCR3-B dramatically reduced DNA synthesis and up-regulated apoptotic HMEC-1 death through activation of distinct signal transduction pathways. Remarkably, primary cultures of human microvascular endothelial cells, whose growth is inhibited by CXCL9, CXCL10, CXCL11, and CXCL4, expressed CXCR3-B, but not CXCR3-A. Finally, monoclonal antibodies raised to selectively recognize CXCR3-B reacted with endothelial cells from neoplastic tissues, providing evidence that CXCR3-B is also expressed in vivo and may account for the angiostatic effects of CXC chemokines.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
1 retracted
Aronica, S. M., Mantel, C., Gonin, R., Marshall, M. S., Sarris, A. H., Cooper, S. H., Hague, N. L., Zhang, X.-F., & Broxmeyer, H. E. (1995) · Journal of Biological Chemistry · doi:10.1074/jbc.270.37.21998 · Cited by 33
RetractedZlotnik, A., & Yoshie, O. (2000) · Immunity · doi:10.1016/s1074-7613(00)80165-x · Cited by 3,859
Haine, M. M.-L., & Meeùs, N. (1986) · Cited by 3,464
The Biology of Chemokines and their Receptors
Rossi, D., & Zlotnik, A. (2000) · Annual Review of Immunology · doi:10.1146/annurev.immunol.18.1.217 · Cited by 2,410
DeLean, A., Munson, P. J., & Rodbard, D. (1978) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.1978.235.2.e97 · Cited by 2,374
Bonecchi, R., Bianchi, G., Bordignon, P. P., D'Ambrosio, D., Lang, R., Borsatti, A., Sozzani, S., Allavena, P., Gray, P. A., Mantovani, A., et al. (1998) · The Journal of Experimental Medicine · doi:10.1084/jem.187.1.129 · Cited by 2,014
Flexible Programs of Chemokine Receptor Expression on Human Polarized T Helper 1 and 2 Lymphocytes
Sallusto, F., Lenig, D., Mackay, C. R., & Lanzavecchia, A. (1998) · The Journal of Experimental Medicine · doi:10.1084/jem.187.6.875 · Cited by 1,542
HMEC-1: Establishment of an Immortalized Human Microvascular Endothelial Cell Line
Ades, E. W., Candal, F. J., Swerlick, R. A., George, V. G., Summers, S., Bosse, D. C., & Lawley, T. J. (1992) · Journal of Investigative Dermatology · doi:10.1111/1523-1747.ep12613748 · Cited by 1,265
The Functional Role of the ELR Motif in CXC Chemokine-mediated Angiogenesis
Strieter, R. M., Polverini, P. J., Kunkel, S. L., Arenberg, D. A., Burdick, M. D., Kasper, J., Dzuiba, J., Van Damme, J., Walz, A., Marriott, D., et al. (1995) · Journal of Biological Chemistry · doi:10.1074/jbc.270.45.27348 · Cited by 1,222
Loetscher, M., Gerber, B., Loetscher, P., Jones, S. A., Piali, L., Clark-Lewis, I., Baggiolini, M., & Moser, B. (1996) · The Journal of experimental medicine · doi:10.1084/jem.184.3.963 · Cited by 1,193
Enzyme changes in neonatal skeletal muscle: effect of thyroid deficiency
Baldwin, K. M., Hooker, A. M., Campbell, P. J., & Lewis, R. E. (1978) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.1978.235.3.c97 · Cited by 1,118
G-protein-coupled receptors and signaling networks: emerging paradigms
Marinissen, M. J., & Gutkind, J. S. (2001) · Trends in Pharmacological Sciences · doi:10.1016/s0165-6147(00)01678-3 · Cited by 1,049
CXC chemokines in angiogenesis
Belperio, J. A., Keane, M. P., Arenberg, D. A., Addison, C. L., Ehlert, J. E., Burdick, M. D., & Strieter, R. M. (2000) · Journal of Leukocyte Biology · doi:10.1189/jlb.68.1.1 · Cited by 804
Inhibition of Angiogenesis by Recombinant Human Platelet Factor-4 and Related Peptides
Maione, T. E., Gray, G. S., Petro, J., Hunt, A. J., Donner, A. L., Bauer, S. I., Carson, H. F., & Sharpe, R. J. (1990) · Science · doi:10.1126/science.1688470 · Cited by 697
Luster, A. D., Greenberg, S. M., & Leder, P. (1995) · The Journal of experimental medicine · doi:10.1084/jem.182.1.219 · Cited by 446
Chemokines: agents for the immunotherapy of cancer?
Homey, B., Müller, A., & Zlotnik, A. (2002) · Nature Reviews Immunology · doi:10.1038/nri748 · Cited by 398
Romagnani, P., Annunziato, F., Lasagni, L., Lazzeri, E., Beltrame, C., Francalanci, M., Uguccioni, M., Galli, G., Cosmi, L., Maurenzig, L., et al. (2001) · Journal of Clinical Investigation · doi:10.1172/jci9775 · Cited by 379
Self-citationArenberg, D. A., Kunkel, S. L., Polverini, P. J., Morris, S. B., Burdick, M. D., Glass, M. C., Taub, D. T., Iannettoni, M. D., Whyte, R. I., & Strieter, R. M. (1996) · The Journal of experimental medicine · doi:10.1084/jem.184.3.981 · Cited by 353
Cutting Edge: Selective Usage of Chemokine Receptors by Plasmacytoid Dendritic Cells
Penna, G., Sozzani, S., & Adorini, L. (2001) · The Journal of Immunology · doi:10.4049/jimmunol.167.4.1862 · Cited by 323
Signal Transduction by the Chemokine Receptor CXCR3
Bonacchi, A., Romagnani, P., Romanelli, R. G., Efsen, E., Annunziato, F., Lasagni, L., Francalanci, M., Serio, M., Laffi, G., Pinzani, M., et al. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m010303200 · Cited by 300
Self-citationMig, the Monokine Induced By Interferon-γ, Promotes Tumor Necrosis In Vivo
Sgadari, C., Farber, J. M., Angiolillo, A. L., Liao, F., Teruya-Feldstein, J., Burd, P. R., Yao, L., Gupta, G., Kanegane, C., & Tosato, G. (1997) · Blood · doi:10.1182/blood.v89.8.2635 · Cited by 246
Salcedo, R., Resau, J. H., Halverson, D., Hudson, E. A., Dambach, M., Powell, D., Wasserman, K., & Oppenheim, J. J. (2000) · The FASEB Journal · doi:10.1096/fj.99-0963com · Cited by 245
The CC chemokine 6Ckine binds the CXC chemokine receptor CXCR3
Soto, H., Wang, W., Strieter, R. M., Copeland, N. G., Gilbert, D. J., Jenkins, N. A., Hedrick, J., & Zlotnik, A. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.14.8205 · Cited by 236
Studies of human plate alpha-granule release in vivo
Files, J., Malpass, T., Yee, E., Ritchie, J., & Harker, L. (1981) · Blood · doi:10.1182/blood.v58.3.607.607 · Cited by 202
Gengrinovitch, S., Greenberg, S. M., Cohen, T., Gitay-Goren, H., Rockwell, P., Maione, T. E., Levi, B.-Z., & Neufeld, G. (1995) · Journal of Biological Chemistry · doi:10.1074/jbc.270.25.15059 · Cited by 198
Tanaka, T., Manome, Y., Wen, P., Kufe, D. W., & Fine, H. A. (1997) · Nature Medicine · doi:10.1038/nm0497-437 · Cited by 197
Janatpour, M. J., Hudak, S., Sathe, M., Sedgwick, J. D., & McEvoy, L. M. (2001) · The Journal of Experimental Medicine · doi:10.1084/jem.194.9.1375 · Cited by 175
Perollet, C., Han, Z. C., Savona, C., Caen, J. P., & Bikfalvi, A. (1998) · Blood · doi:10.1182/blood.v91.9.3289 · Cited by 169
Romagnani, P., Rotondi, M., Lazzeri, E., Lasagni, L., Francalanci, M., Buonamano, A., Milani, S., Vitti, P., Chiovato, L., Tonacchera, M., et al. (2002) · The American Journal of Pathology · doi:10.1016/s0002-9440(10)64171-5 · Cited by 161
Self-citationInhibition of endothelial cell survival and angiogenesis by protein kinase A
Kim, S., Bakre, M., Yin, H., & Varner, J. A. (2002) · Journal of Clinical Investigation · doi:10.1172/jci14268 · Cited by 160
Rappert, A., Biber, K. P. H., Nolte, C., Lipp, M., Schubel, A., Lu, B., Gerard, N. P., Gerard, C. J., Boddeke, H. W. G. M., & Kettenmann, H. (2002) · The Journal of Immunology · doi:10.4049/jimmunol.168.7.3221 · Cited by 159
Cognition and White Matter Lesions
Desmond, D. W. (2002) · Cerebrovascular Diseases · doi:10.1159/000049151 · Cited by 152
Pupilli, C., Lasagni, L., Romagnani, P., Bellini, F., Mannelli, M., Misciglia, N., Mavilia, C., VELLEI, U., Villari, D., & Serio, M. (1999) · Journal of the American Society of Nephrology · doi:10.1681/asn.v102245 · Cited by 151
Self-citationInhibition of endothelial cell survival and angiogenesis by protein kinase A
Kim, S., Bakre, M. M., Yin, H. X., & Varner, J. A. (2002) · Journal of Clinical Investigation · doi:10.1172/jci0214268 · Cited by 150
Maione, T. E., Gray, G. S., Hunt, A. J., et al. (1991) · PubMed · Cited by 148
Shiraha, H., Glading, A., Gupta, K. B., & Wells, A. H. (1999) · The Journal of Cell Biology · doi:10.1083/jcb.146.1.243 · Cited by 142
Pugliese, G., Pricci, F., Romeo, G. R., Pugliese, F. R., Mené, P., Giannini, S., Cresci, B., Galli, G., Rotella, C. M., Vlassara, H., et al. (1997) · Diabetes · doi:10.2337/diab.46.11.1881 · Cited by 135
Self-citationRomagnani, P., Lazzeri, E., Lasagni, L., Mavilia, C., Beltrame, C., Francalanci, M., Rotondi, M., Annunziato, F., Maurenzig, L., Cosmi, L., et al. (2002) · Journal of the American Society of Nephrology · doi:10.1681/asn.v13153 · Cited by 124
Self-citationRole for Interactions Between IP-10/Mig and CXCR3 in Proliferative Glomerulonephritis
Romagnani, P., Beltrame, C., Annunziato, F., Lasagni, L., Luconi, M., Galli, G., Cosmi, L., Maggi, E., Salvadori, M., Pupilli, C., et al. (1999) · Journal of the American Society of Nephrology · doi:10.1681/asn.v10122518 · Cited by 113
Self-citationInhibition of In Vitro Angiogenesis by Platelet Factor-4–Derived Peptides and Mechanism of Action
Jouan–Hureaux, V., Canron, X., Alemany, M., Caen, J., Quentin, G., Plouët, J., & Bikfalvi, A. (1999) · Blood · doi:10.1182/blood.v94.3.984.415k31_984_993 · Cited by 113
Couty, J., Geras‐Raaka, E., Weksler, B. B., & Gershengorn, M. C. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m104631200 · Cited by 98
CXC Chemokines in Angiogenesis Related to Pulmonary Fibrosis*
Strieter, R. M., Belperio, J. A., & Keane, M. P. (2002) · CHEST Journal · doi:10.1378/chest.122.6_suppl.298s · Cited by 80
Gentilini, G., Kirschbaum, N. E., Augustine, J. A., Aster, R. H., & Visentin, G. P. (1999) · Blood · doi:10.1182/blood.v93.1.25 · Cited by 79
Regland, B., Blennow, K., Germgård, T., Koch-Schmidt, A.-C., & Gottfries, C. (1999) · Dementia and Geriatric Cognitive Disorders · doi:10.1159/000017127 · Cited by 76
Jenh, C., Cox, M. A., Kaminski, H., Zhang, M., Byrnes, H. D., Fine, J. S., Lundell, D. J., Chou, C., Narula, S. K., & Zavodny, P. J. (1999) · The Journal of Immunology · doi:10.4049/jimmunol.162.7.3765 · Cited by 67
Sulpice, E., Bryckaert, M., Lacour, J., Contrerès, J.-O., & Tobelem, G. (2002) · Blood · doi:10.1182/blood.v100.9.3087 · Cited by 63
Arenberg, D. A., Zlotnick, A., Strom, S. R. B., Burdick, M. D., & Strieter, R. M. (2001) · Cancer Immunology Immunotherapy · doi:10.1007/s002620000147 · Cited by 62
Gröne, H., Cohen, C. D., Diaeresis]ne, E. G., Schmidt, C. S., Kretzler, M., Diaeresis]ndorff, D. S., & Nelson, P. J. (2002) · Journal of the American Society of Nephrology · doi:10.1681/asn.v134957 · Cited by 57
Lecomte-Raclet, L., Alemany, M., Grand, A. S.-L., Amiral, J., Quentin, G., Vissac, A. M., Caen, J., & Han, Z. (1998) · Blood · doi:10.1182/blood.v91.8.2772.2772_2772_2780 · Cited by 40
Zhou, Y., Wang, S., Yue, B., Gobl, A., & Öberg, K. (2002) · Cancer Investigation · doi:10.1081/cnv-120001180 · Cited by 26
Cited by
Tumor angiogenesis: causes, consequences, challenges and opportunities
Lugano, R., Ramachandran, M., & Dimberg, A. (2020) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-019-03351-7 · Cited by 1,986
CXCL9, CXCL10, CXCL11/CXCR3 axis for immune activation - a target for novel cancer therapy
Tokunaga, R., Zhang, W., Naseem, M., Puccini, A., Berger, M. D., Soni, S., McSkane, M., Baba, H., & Lenz, H.-J. (2018) · Cancer Treatment Reviews · doi:10.1016/j.ctrv.2017.11.007 · Cited by 1,627
A guide to chemokines and their receptors
Hughes, C. E., & Nibbs, R. J. B. (2018) · The FEBS Journal · doi:10.1111/febs.14466 · Cited by 1,412
G-protein-coupled receptors and cancer
Dorsam, R. T., & Gutkind, J. S. (2007) · Nature Reviews Cancer · doi:10.1038/nrc2069 · Cited by 1,388
The Chemokine Superfamily Revisited
Zlotnik, A., & Yoshie, O. (2012) · Immunity · doi:10.1016/j.immuni.2012.05.008 · Cited by 1,235
Metadata
- Authors
- Lasagni, L., Francalanci, M., Annunziato, F., Lazzeri, E., Giannini, S., Cosmi, L., Sagrinati, C., Mazzinghi, B., Orlando, C., Maggi, E., Marra, F., Romagnani, S., Serio, M., & Romagnani, P.
- Venue
- The Journal of Experimental Medicine
- Publisher
- Rockefeller University Press
- Published
- 2003-06-02
- Volume
- 197
- Issue
- 11
- Pages
- 1537-1549
- ISSN
- 0022-1007 (ISSN-L)
- 1540-9538
- OpenAlex
- W2029824788
- Cited by
- 739
- References
- 50
- FWCI
- 15.64
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.